Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CNS vs BLK

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CNS
Cohen & Steers, Inc.

Asset Management

Financial ServicesNYSE • US
Market Cap$3.63B
5Y Perf.+11.9%
BLK
BlackRock, Inc.

Asset Management

Financial ServicesNYSE • US
Market Cap$165.65B
5Y Perf.+102.0%

CNS vs BLK — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CNS logoCNS
BLK logoBLK
IndustryAsset ManagementAsset Management
Market Cap$3.63B$165.65B
Revenue (TTM)$517M$20.41B
Net Income (TTM)$164M$6.10B
Gross Margin46.8%49.4%
Operating Margin33.4%37.1%
Forward P/E20.8x20.1x
Total Debt$141M$14.22B
Cash & Equiv.$183M$12.76B

CNS vs BLKLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CNS
BLK
StockMay 20May 26Return
Cohen & Steers, Inc. (CNS)100111.9+11.9%
BlackRock, Inc. (BLK)100202.0+102.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: CNS vs BLK

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BLK leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Cohen & Steers, Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
CNS
Cohen & Steers, Inc.
The Banking Pick

CNS is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 2 yrs, beta 0.98, yield 3.3%
  • Lower volatility, beta 0.98, Low D/E 24.5%, current ratio 25.39x
  • Beta 0.98, yield 3.3%, current ratio 25.39x
Best for: income & stability and sleep-well-at-night
BLK
BlackRock, Inc.
The Banking Pick

BLK carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 14.3%, EPS growth 15.1%
  • 245.8% 10Y total return vs CNS's 154.3%
  • PEG 2.47 vs CNS's 16.52
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthBLK logoBLK14.3% NII/revenue growth vs CNS's 5.7%
ValueBLK logoBLKLower P/E (20.1x vs 20.8x), PEG 2.47 vs 16.52
Quality / MarginsBLK logoBLKEfficiency ratio 0.1% vs CNS's 0.1% (lower = leaner)
Stability / SafetyCNS logoCNSBeta 0.98 vs BLK's 1.28, lower leverage
DividendsCNS logoCNS3.3% yield, 2-year raise streak, vs BLK's 1.9%
Momentum (1Y)BLK logoBLK+18.3% vs CNS's -5.2%
Efficiency (ROA)BLK logoBLKEfficiency ratio 0.1% vs CNS's 0.1%

CNS vs BLK — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CNSCohen & Steers, Inc.
FY 2024
Open-End Investment Funds
55.7%$288M
Institutional Accounts
24.9%$129M
Closed-End Investment Funds
19.3%$100M
BLKBlackRock, Inc.
FY 2024
Investment Advice
78.9%$16.1B
Technology Service
7.9%$1.6B
Distribution and Shareholder Service
6.2%$1.3B
Investment Performance
5.9%$1.2B
Service, Other
1.1%$224M

CNS vs BLK — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBLKLAGGINGCNS

Income & Cash Flow (Last 12 Months)

BLK leads this category, winning 4 of 5 comparable metrics.

BLK is the larger business by revenue, generating $20.4B annually — 39.4x CNS's $517M. Profitability is closely matched — net margins range from 31.2% (BLK) to 29.2% (CNS).

MetricCNS logoCNSCohen & Steers, I…BLK logoBLKBlackRock, Inc.
RevenueTrailing 12 months$517M$20.4B
EBITDAEarnings before interest/tax$198M$8.3B
Net IncomeAfter-tax profit$164M$6.1B
Free Cash FlowCash after capex-$94M$3.9B
Gross MarginGross profit ÷ Revenue+46.8%+49.4%
Operating MarginEBIT ÷ Revenue+33.4%+37.1%
Net MarginNet income ÷ Revenue+29.2%+31.2%
FCF MarginFCF ÷ Revenue+16.4%+23.0%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+5.2%-22.7%
BLK leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

BLK leads this category, winning 4 of 7 comparable metrics.

At 23.9x trailing earnings, CNS trades at a 6% valuation discount to BLK's 25.4x P/E. Adjusting for growth (PEG ratio), BLK offers better value at 3.13x vs CNS's 19.03x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCNS logoCNSCohen & Steers, I…BLK logoBLKBlackRock, Inc.
Market CapShares × price$3.6B$165.7B
Enterprise ValueMkt cap + debt − cash$3.6B$167.1B
Trailing P/EPrice ÷ TTM EPS23.94x25.42x
Forward P/EPrice ÷ next-FY EPS est.20.79x20.10x
PEG RatioP/E ÷ EPS growth rate19.03x3.13x
EV / EBITDAEnterprise value multiple19.48x20.62x
Price / SalesMarket cap ÷ Revenue7.01x8.12x
Price / BookPrice ÷ Book value/share6.30x3.28x
Price / FCFMarket cap ÷ FCF42.64x35.24x
BLK leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

CNS leads this category, winning 7 of 8 comparable metrics.

CNS delivers a 28.3% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $10 for BLK. CNS carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to BLK's 0.29x. On the Piotroski fundamental quality scale (0–9), BLK scores 6/9 vs CNS's 5/9, reflecting solid financial health.

MetricCNS logoCNSCohen & Steers, I…BLK logoBLKBlackRock, Inc.
ROE (TTM)Return on equity+28.3%+9.9%
ROA (TTM)Return on assets+20.5%+3.7%
ROICReturn on invested capital+19.2%+9.9%
ROCEReturn on capital employed+22.8%+5.8%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage0.25x0.29x
Net DebtTotal debt minus cash-$42M$1.5B
Cash & Equiv.Liquid assets$183M$12.8B
Total DebtShort + long-term debt$141M$14.2B
Interest CoverageEBIT ÷ Interest expense9.27x
CNS leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

BLK leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in BLK five years ago would be worth $13,352 today (with dividends reinvested), compared to $11,824 for CNS. Over the past 12 months, BLK leads with a +18.3% total return vs CNS's -5.2%. The 3-year compound annual growth rate (CAGR) favors BLK at 20.7% vs CNS's 13.0% — a key indicator of consistent wealth creation.

MetricCNS logoCNSCohen & Steers, I…BLK logoBLKBlackRock, Inc.
YTD ReturnYear-to-date+12.9%-1.1%
1-Year ReturnPast 12 months-5.2%+18.3%
3-Year ReturnCumulative with dividends+44.3%+75.7%
5-Year ReturnCumulative with dividends+18.2%+33.5%
10-Year ReturnCumulative with dividends+154.3%+245.8%
CAGR (3Y)Annualised 3-year return+13.0%+20.7%
BLK leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CNS and BLK each lead in 1 of 2 comparable metrics.

CNS is the less volatile stock with a 0.98 beta — it tends to amplify market swings less than BLK's 1.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricCNS logoCNSCohen & Steers, I…BLK logoBLKBlackRock, Inc.
Beta (5Y)Sensitivity to S&P 5000.98x1.28x
52-Week HighHighest price in past year$83.99$1219.94
52-Week LowLowest price in past year$58.39$914.84
% of 52W HighCurrent price vs 52-week peak+84.7%+87.5%
RSI (14)Momentum oscillator 0–10063.161.3
Avg Volume (50D)Average daily shares traded323K790K
Evenly matched — CNS and BLK each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CNS and BLK each lead in 1 of 2 comparable metrics.

Wall Street rates CNS as "Sell" and BLK as "Buy". Consensus price targets imply 22.8% upside for BLK (target: $1312) vs 6.9% for CNS (target: $76). For income investors, CNS offers the higher dividend yield at 3.29% vs BLK's 1.92%.

MetricCNS logoCNSCohen & Steers, I…BLK logoBLKBlackRock, Inc.
Analyst RatingConsensus buy/hold/sellSellBuy
Price TargetConsensus 12-month target$76.00$1311.78
# AnalystsCovering analysts1333
Dividend YieldAnnual dividend ÷ price+3.3%+1.9%
Dividend StreakConsecutive years of raises215
Dividend / ShareAnnual DPS$2.34$20.46
Buyback YieldShare repurchases ÷ mkt cap+0.6%+1.2%
Evenly matched — CNS and BLK each lead in 1 of 2 comparable metrics.
Key Takeaway

BLK leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CNS leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallBlackRock, Inc. (BLK)Leads 3 of 6 categories
Loading custom metrics...

CNS vs BLK: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CNS or BLK a better buy right now?

For growth investors, BlackRock, Inc.

(BLK) is the stronger pick with 14. 3% revenue growth year-over-year, versus 5. 7% for Cohen & Steers, Inc. (CNS). Cohen & Steers, Inc. (CNS) offers the better valuation at 23. 9x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate BlackRock, Inc. (BLK) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CNS or BLK?

On trailing P/E, Cohen & Steers, Inc.

(CNS) is the cheapest at 23. 9x versus BlackRock, Inc. at 25. 4x. On forward P/E, BlackRock, Inc. is actually cheaper at 20. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: BlackRock, Inc. wins at 2. 47x versus Cohen & Steers, Inc. 's 16. 52x.

03

Which is the better long-term investment — CNS or BLK?

Over the past 5 years, BlackRock, Inc.

(BLK) delivered a total return of +33. 5%, compared to +18. 2% for Cohen & Steers, Inc. (CNS). Over 10 years, the gap is even starker: BLK returned +245. 8% versus CNS's +154. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CNS or BLK?

By beta (market sensitivity over 5 years), Cohen & Steers, Inc.

(CNS) is the lower-risk stock at 0. 98β versus BlackRock, Inc. 's 1. 28β — meaning BLK is approximately 31% more volatile than CNS relative to the S&P 500. On balance sheet safety, Cohen & Steers, Inc. (CNS) carries a lower debt/equity ratio of 25% versus 29% for BlackRock, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CNS or BLK?

By revenue growth (latest reported year), BlackRock, Inc.

(BLK) is pulling ahead at 14. 3% versus 5. 7% for Cohen & Steers, Inc. (CNS). On earnings-per-share growth, the picture is similar: BlackRock, Inc. grew EPS 15. 1% year-over-year, compared to 14. 2% for Cohen & Steers, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CNS or BLK?

BlackRock, Inc.

(BLK) is the more profitable company, earning 31. 2% net margin versus 29. 2% for Cohen & Steers, Inc. — meaning it keeps 31. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BLK leads at 37. 1% versus 33. 4% for CNS. At the gross margin level — before operating expenses — BLK leads at 49. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CNS or BLK more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, BlackRock, Inc. (BLK) is the more undervalued stock at a PEG of 2. 47x versus Cohen & Steers, Inc. 's 16. 52x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, BlackRock, Inc. (BLK) trades at 20. 1x forward P/E versus 20. 8x for Cohen & Steers, Inc. — 0. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BLK: 22. 8% to $1311. 78.

08

Which pays a better dividend — CNS or BLK?

All stocks in this comparison pay dividends.

Cohen & Steers, Inc. (CNS) offers the highest yield at 3. 3%, versus 1. 9% for BlackRock, Inc. (BLK).

09

Is CNS or BLK better for a retirement portfolio?

For long-horizon retirement investors, Cohen & Steers, Inc.

(CNS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), 3. 3% yield, +154. 3% 10Y return). Both have compounded well over 10 years (CNS: +154. 3%, BLK: +245. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CNS and BLK?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CNS is a small-cap income-oriented stock; BLK is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CNS

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 17%
Run This Screen
Stocks Like

BLK

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 18%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CNS and BLK on the metrics below

Revenue Growth>
%
(CNS: 5.7% · BLK: 14.3%)
Net Margin>
%
(CNS: 29.2% · BLK: 31.2%)
P/E Ratio<
x
(CNS: 23.9x · BLK: 25.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.